Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-641


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 340, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
AIMP2 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:6023759-6023787 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RBM28 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr7:128309903-128309927 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SPIN1 hsa-miR-641 low: 0 high: 1 1 1 1 0.639
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr9:88476629-88476650 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCNJ hsa-miR-641 low: 0 high: 1 1 1 1 0.769
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:96060276-96060300 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PDHX hsa-miR-641 low: 0 high: 1 1 1 1 0.460
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr11:34984715-34984737 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SOX6 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr11:15967653-15967674 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARPC3 hsa-miR-641 low: 0 high: 1 1 1 1 0.693
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:110440334-110440353 PAR-CLIP POSITIVE DIRECT TarBase 7.0
GOLT1B hsa-miR-641 low: 0 high: 1 1 1 1 0.565
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:21518101-21518128 HITS-CLIP POSITIVE DIRECT TarBase 7.0
COL12A1 hsa-miR-641 low: 0 high: 1 1 1 1 0.761
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr6:75086171-75086197 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF451 hsa-miR-641 low: 0 high: 1 1 1 1 0.978
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:57101181-57101200 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TMEM30A hsa-miR-641 low: 0 high: 1 1 1 1 0.558
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr6:75256011-75256031 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PDE4D hsa-miR-641 low: 0 high: 1 1 1 1 0.777
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:58971214-58971226 HITS-CLIP POSITIVE DIRECT TarBase 7.0
C5orf15 hsa-miR-641 low: 0 high: 1 1 1 1 0.523
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:133955835-133955862 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TXNDC15 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr5:134875080-134875107 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RARS hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:168497318-168497342 PAR-CLIP POSITIVE DIRECT TarBase 7.0
AMOTL2 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:134356058-134356080 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ACVR2B hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:38484825-38484847 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MOB1A hsa-miR-641 low: 0 high: 1 1 1 1 0.493
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:74155428-74155452 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PLEKHB2 hsa-miR-641 low: 0 high: 1 1 1 1 0.548
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:131149245-131149270 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PHF13 hsa-miR-641 low: 0 high: 1 1 1 1 0.557
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:6622364-6622375 HITS-CLIP POSITIVE DIRECT TarBase 7.0